1. Home
  2. MTEN vs MBIO Comparison

MTEN vs MBIO Comparison

Compare MTEN & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mingteng International Corporation Inc. Ordinary Shares

MTEN

Mingteng International Corporation Inc. Ordinary Shares

HOLD

Current Price

$1.11

Market Cap

5.5M

Sector

Industrials

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.70

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTEN
MBIO
Founded
2015
2015
Country
China
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
5.1M
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
MTEN
MBIO
Price
$1.11
$0.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.4K
44.2K
Earning Date
05-21-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
98.99
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.53
52 Week High
$26.03
$7.00

Technical Indicators

Market Signals
Indicator
MTEN
MBIO
Relative Strength Index (RSI) 49.74 49.59
Support Level $0.85 $0.56
Resistance Level $1.33 $0.80
Average True Range (ATR) 0.10 0.06
MACD 0.01 0.02
Stochastic Oscillator 64.36 49.47

Price Performance

Historical Comparison
MTEN
MBIO

About MTEN Mingteng International Corporation Inc. Ordinary Shares

Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup, including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: